Russell Investments Group’s Cabaletta Bio CABA Stock Holding History

Russell Investments Group’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.9K	Buy	9,941 +9,002	+959%	+$29.6K	﹤0.01%	3729
2026 Q1	$2.53K	Hold	939	–	–	﹤0.01%	3979
2025 Q4	$2.06K	Hold	939	–	–	﹤0.01%	4004
2025 Q3	$2.2K	Hold	939	–	–	﹤0.01%	3996
2025 Q2	$1.43K	Buy	+939	New	+$1.46K	﹤0.01%	3629
2025 Q1	–	Sell	-1,574	Closed	-$3.57K	–	3805
2024 Q4	$3.57K	Buy	+1,574	New	+$5.53K	﹤0.01%	3348
2024 Q3	–	Sell	-224	Closed	-$1.68K	–	3703
2024 Q2	$1.68K	Buy	224 +193	+623%	+$2.37K	﹤0.01%	3373
2024 Q1	$529	Buy	+31	New	+$665	﹤0.01%	3203
2023 Q4	–	Sell	-14	Closed	-$213	–	3219
2023 Q3	$213	Buy	+14	New	+$191	﹤0.01%	3490
2021 Q2	–	Sell	-34,059	Closed	-$377K	–	3213
2021 Q1	$377K	Hold	34,059	–	–	﹤0.01%	2631
2020 Q4	$424K	Sell	34,059 -46,145	-58%	-$599K	﹤0.01%	2495
2020 Q3	$866K	Sell	80,204 -20,961	-21%	-$241K	﹤0.01%	2141
2020 Q2	$1.13M	Buy	+101,165	New	+$775K	﹤0.01%	1984

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Russell Investments Group's CABA Position: Q2 2026 in Review

Russell Investments Group increased its Cabaletta Bio (CABA) stake by 959% in Q2 2026, buying an estimated $29.6K and bringing the position to 9,941 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3729.

Russell Investments Group first reported a position in CABA in Q2 2020 and has held it in 13 quarters since. The position peaked at $1.13M in Q2 2020. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Russell Investments Group held 9,941 shares of Cabaletta Bio worth $30.9K as of Q2 2026.
Russell Investments Group bought 9,002 Cabaletta Bio shares in Q2 2026, an estimated $29.6K.
Cabaletta Bio made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3729 holding.
Russell Investments Group first reported a position in Cabaletta Bio in Q2 2020 and has held it in 13 quarters since.
Russell Investments Group's Cabaletta Bio position peaked at $1.13M in Q2 2020.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.